Stock Weekly: Correvio Pharma (CORV:56.0c) increases 1.8% on firm volume
CANADIAN WEEKLY STOCK REPORT
Correvio Pharma Corp. (TSX:CORV), Canada's 28th largest Biotechnology company by market cap, has increased 1.0c (or 1.8%) in the past week to close at 56.0c. Compared with the S&P/TSX 60 Index which rose 21.9 points (or 2.5%) in the week, this represented a relative price change of -0.8%. The volume was 1.1 times average trading per week of 228,570 shares. In the past week the market cap has risen CAD505,057 (US$362,241).